{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:18:11Z","timestamp":1761718691676},"reference-count":29,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T00:00:00Z","timestamp":1525824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The physical, social and mental burden of psoriasis is well known, but its occupational impact has been less investigated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To assess the impact of psoriasis on the working life of patients compared with the general population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A national survey compared people with and without psoriasis using online questionnaires. In addition to the demographic, medical and professional characteristics, data on recent absenteeism and presenteeism were captured using the validated <jats:styled-content style=\"fixed-case\">WPAI<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">PSO<\/jats:styled-content> questionnaire.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The patient sample comprised 714 with psoriasis (PsO), including 81 treated with systemic therapies (Pso<jats:styled-content style=\"fixed-case\">ST<\/jats:styled-content>), and 84 with associated psoriatic arthritis (PsO\u00a0+\u00a0PsA). The control sample comprised 604 active subjects representative of the French population. Compared to controls, the impact of the disease on working life was no greater in PsO patients. Conversely, unemployment within the past 5\u00a0years and mean number of sick leaves within the previous year were more frequent in PsO\u00a0+\u00a0PsA. In patients with active psoriasis skin lesions, all aspects of the <jats:styled-content style=\"fixed-case\">WPAI<\/jats:styled-content> questionnaire were negatively impacted in Pso<jats:styled-content style=\"fixed-case\">ST<\/jats:styled-content> and PsO\u00a0+\u00a0PsA patients, but not in PsO patients: Levels of absenteeism were 3.3% in controls, 5.6% in PsO (<jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content>), 8.3% in Pso<jats:styled-content style=\"fixed-case\">ST<\/jats:styled-content> (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05) and 13.0% in Ps0\u00a0+\u00a0PsA (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05); impairment in presenteeism reached 27.0%, 21.2% (<jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content>), 43.5% (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05) and 53.2% (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05), respectively, while overall work impairment was 27.9%, 22.2% (<jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content>), 46.3% (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05) and 57.6% (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05), respectively. Nevertheless, a higher proportion of Pso<jats:styled-content style=\"fixed-case\">ST<\/jats:styled-content> and PsO\u00a0+\u00a0PsA patients reported that work was more important than any other activity in their life.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The occupational impact of psoriasis is important and significant in patients who receive systemic therapy or have concurrent PsA but minimal or absent in other psoriasis patients. The findings show that psoriasis patients have a high level of motivation to work.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jdv.14986","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T06:43:49Z","timestamp":1523342629000},"page":"1702-1709","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The impact of psoriasis on professional life: Pso<scp>PRO<\/scp>, a French national survey"],"prefix":"10.1111","volume":"32","author":[{"given":"P.","family":"Claudepierre","sequence":"first","affiliation":[{"name":"Department of Rheumatology AP\u2010HP CHU Henri Mondor Cr\u00e9teil France"},{"name":"Universit\u00e9 Paris Est Cr\u00e9teil EA 7379 \u2013 EpidermE Cr\u00e9teil France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lahfa","sequence":"additional","affiliation":[{"name":"Dermatologie practice Biarritz France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Levy","sequence":"additional","affiliation":[{"name":"Department of Economics Universit\u00e9 Paris\u2010Dauphine PSL Research University LEDa[LEGOS] Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Barnetche","sequence":"additional","affiliation":[{"name":"Department of Rheumatology FHU ACRONIM Centre Hospitalier Universitaire (CHU) Bordeaux Pellegrin Bordeaux France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Bonnet","sequence":"additional","affiliation":[{"name":"Department of Rheumatology AP\u2010HP CHU Henri Mondor Cr\u00e9teil France"},{"name":"Universit\u00e9 Paris Est Cr\u00e9teil EA 7379 \u2013 EpidermE Cr\u00e9teil France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Aubert","sequence":"additional","affiliation":[{"name":"Patient Advocacy Group France Psoriasis Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Roquelaure","sequence":"additional","affiliation":[{"name":"Medicine and Occupational Health Centre Hospitalier Universitaire (CHU) Angers Angers France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,5,9]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.07.023"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.339"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1159\/000182258"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.62754"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1159\/000345715"},{"key":"e_1_2_7_7_1","first-page":"504","article-title":"The challenge of managing psoriasis: unmet medical needs and stakeholder perspectives","volume":"9","author":"Feldman SR","year":"2016","journal-title":"Am Health Drug Benefits"},{"key":"e_1_2_7_8_1","doi-asserted-by":"crossref","DOI":"10.5070\/D3208023523","article-title":"Social impact of the burden of psoriasis: effects on patients and practice","volume":"20","author":"Feldman SR","year":"2014","journal-title":"Dermatol Online J"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-016-1321-7"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052935"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2009.08068"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-016-0029-z"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12841"},{"key":"e_1_2_7_14_1","doi-asserted-by":"crossref","first-page":"000","DOI":"10.5070\/D3227031643","article-title":"Impact of psoriasis flare and remission on quality of life and work productivity: a real\u2010world study in the USA","volume":"22","author":"Korman NJ","year":"2016","journal-title":"Dermatol Online J"},{"key":"e_1_2_7_15_1","first-page":"199","article-title":"Analysis of the relationship between psoriasis symptom severity and quality of life, work productivity, and activity impairment among patients with moderate\u2010to\u2010severe psoriasis using structural equation\u00a0modeling","volume":"7","author":"Lewis\u2010Beck C","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"e_1_2_7_16_1","first-page":"1506","article-title":"The relationship between disease, work and sickness absence among psoriasis patients","volume":"44","author":"Mansouri P","year":"2015","journal-title":"Iran J Public Health"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03600.x"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-015-0752-0"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546630500482886"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1159\/000093848"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1957-2557(16)30132-8"},{"key":"e_1_2_7_22_1","volume-title":"ECHANTILLON REPRE SENTATIF (D'UNE POPULATION FINIE): DEFINITION STATISTIQUE ET PROPRIETES. Echantillon repr\u00e9sentatif, Sondage, Quotas, Probabilit\u00e9s d'inclusion","author":"Lerville\u2010R\u00e9ache L","year":"2011"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199304050-00006"},{"key":"e_1_2_7_24_1","unstructured":"Institut National de la Statistique et des Etudes Economiques. Logements individus activit\u00e9 mobilit\u00e9s scolaires et professionnelles en 2012\u2010 Recensement de la population. Available at:https:\/\/www.insee.fr\/fr\/statistiques\/1912584(Last Accessed 18 April 2018)."},{"key":"e_1_2_7_25_1","unstructured":"Ameli.fr l\u2019assurance maladie. Pr\u00e9valence des ALD [chronic long\u2010term health condition] en.2016\u2010 Available at:https:\/\/www.ameli.fr\/l-assurance-maladie\/statistiques-et-publications\/donnees-statistiques\/affection-de-longue-duree-ald\/prevalence\/prevalence-des-ald-en-2016.php(Last Accessed 18 April 2018)."},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.12.018"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.03990.x"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39573"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.12.1493"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-013-0032-x"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.14986","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.14986","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T07:00:34Z","timestamp":1694847634000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.14986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,9]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1111\/jdv.14986"],"URL":"https:\/\/doi.org\/10.1111\/jdv.14986","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,9]]},"assertion":[{"value":"2017-12-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}